Dr. Ehmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Dr
Hershey, PA 17033Phone+1 800-233-4082
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1986 - 1987
- NYU Grossman School of MedicineResidency, Internal Medicine, 1984 - 1986
- Brown UniversityResidency, Internal Medicine, 1980 - 1981
- Albany Medical CollegeClass of 1980
Certifications & Licensure
- NY State Medical License 1984 - Present
- PA State Medical License 1988 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 18 citationsA phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia.Hong Zheng, Shin Mineishi, David F. Claxton, Junjia Zhu, Chenchen Zhao
American Journal of Hematology. 2021-02-01 - 12 citationsMulti-dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML.Chenchen Zhao, Bei Jia, Ming Wang, Todd D. Schell, David F. Claxton
British Journal of Haematology. 2020-03-01 - 38 citationsEomes+T-betlow CD8+ T cells are functionally impaired and are associated with poor clinical outcome in patients with acute myeloid leukemiaBei Jia, Chenchen Zhao, Kevin Rakszawski, David F. Claxton, W. Christopher Ehmann
Cancer Research. 2019-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: